Discover the Next Generation of Precise, Safe & Effective Gene Editing Approaches
CRISPR is one of the most powerful discoveries of the last decade, and we are now heralding in the era of gene editing.
In the time since its discovery, CRISPR has rapidly become an established tool in the genomics toolbox. Now the question is: What next?
The CRISPR 2.0 Summit is devoted to showcasing only the latest and greatest innovations by uncovering how the next generation of CRISPR tools are radically enhancing efficacy, minimizing off-target effects & enabling efficient delivery to specific tissues to ensure you stay at the forefront of this rapidly exploding field.
Discover the promise of novel Cas variants, base and prime editing approaches, innovative delivery mechanisms, and the applications of these next generation tools through learnings from CRISPR clinical trials and new & unpublished data.
Don’t get left behind. Join 100+ leading pharma and biotech companies pioneering CRISPR-based therapeutics into the clinic to usher in the next generation of safe, targeted and effective genome editing.
View the event guide now for the full agenda!
Don't Just Take Our Word For It!
"Well organized presentations into thematic groups of timely topics that the field is grappling with"
Scribe Therapeutics, Past attendee, CRISPR Event Series
"I greatly enjoyed the diversity and topic coverage of the talks, thanks for putting together an excellent program!"
Syros Pharmaceuticals, Past attendee, CRISPR Event Series
Discuss methods to overcome CRISPR delivery challenges
Delve into the latest delivery platforms and the innovative work being done to develop viral and non-viral candidates suitable for ex-vivo and in-vivo delivery with Scribe Therapeutics
Explore the potential of prime editing
Hear directly from
member of the
Liu Group, who
is responsible for
Discover the latest developments in base editing
Learn about improvements to further reduce off-target effects and how to detect off-target effects of base editors to ease regulator concerns with Astrazeneca
Investigate novel Cas variants
Understand how novel Cas proteins that optimize specificity and efficacy of gene editing will be vital to bringing CRISPR successfully into the clinic with Arbor Biotech